Rosette nanotubes show low acute pulmonary toxicity in vivo by Journeay, W Shane et al.
© 2008 Journeay et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access 
article which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Nanomedicine 2008:3(3) 373–383 373
ORIGINAL RESEARCH
Rosette nanotubes show low acute pulmonary 
toxicity in vivo
W Shane Journeay1
Sarabjeet S Suri1
Jesus G Moralez2
Hicham Fenniri2
Baljit Singh1
1Immunology Research Group, 
Toxicology Graduate Program 
and Department of Veterinary 
Biomedical Sciences, Western College 
of Veterinary Medicine, University 
of Saskatchewan, 52 Campus Drive, 
Saskatoon, SK, S7N 5B4, Canada; 
2National Institute of Nanotechnology, 
National Research Council 
(NINT-NRC) and Department 
of Chemistry, University of Alberta, 
11421 Saskatchewan Drive, Edmonton, 
AB, T6G 2M9, Canada
Correspondence: Baljit Singh
Immunology Research Group, Toxicology 
Graduate Program and Department of 
Veterinary Biomedical Sciences, Western 
College of Veterinary Medicine, University 
of Saskatchewan, 52 Campus Drive, 
Saskatoon, SK, S7N 5B4, Canada
Tel +1 306 966 7408
Fax +1 306 966 7405
Email baljit.singh@usask.ca
Abstract: Nanotubes are being developed for a large variety of applications ranging from 
electronics to drug delivery. Common carbon nanotubes such as single-walled and multi-walled 
carbon nanotubes have been studied in the greatest detail but require solubilization and removal of 
catalytic contaminants such as metals prior to being introduced to biological systems for medical 
application. The present in vivo study characterizes the degree and nature of inﬂ  ammation caused 
by a novel class of self-assembling rosette nanotubes, which are biologically inspired, naturally 
water-soluble and free of metal content upon synthesis. Upon pulmonary administration of this 
material we examined responses at 24 h and 7d post-exposure. An acute inﬂ  ammatory response 
is triggered at 50 and 25 μg doses by 24 h post-exposure but an inﬂ  ammatory response is not 
triggered by a 5 μg dose. Lung inﬂ  ammation observed at a 50 μg dose at 24 h was resolving by 
7d. This work suggests that novel nanostructures with biological design may negate toxicity con-
cerns for biomedical applications of nanotubes. This study also demonstrates that water-soluble 
rosette nanotube structures represent low pulmonary toxicity, likely due to their biologically 
inspired design, and their self-assembled architecture.
Keywords: nanotoxicology, biocompatibility, nanomedicine, pulmonary drug delivery, lung 
inﬂ  ammation
Introduction
Nanotechnology is a rapidly evolving interdisciplinary research area offering great 
potential for applications to such ﬁ  elds as electronics, materials science, drug delivery, 
medical imaging and diagnosis. It has been estimated that nanotechnology will have a 
market of US$1 trillion by 2015 (Nel et al 2006). New nanomaterials and nanodevices 
are being developed with the intention of improving everyday life (Roco 2004), but 
efforts are also being devoted to understand the possible toxicity and health implica-
tions of engineered nanomaterials. Knowledge of such factors is also considered a 
potential barrier to public acceptance, commercialization, and future development of 
nanotechnology, and therefore warrants more research.
Materials at the nanoscale possess some unique physicochemical properties 
(Nel et al 2006) which make them attractive for their intended use but may also 
confer challenges upon those evaluating their potential toxicity. Indeed, some of the 
concerns about possible toxicity of engineered nanomaterials have been raised from 
our understanding of ultraﬁ  ne particle toxicity research (Oberdörster et al 2005b; 
Kreyling et al 2006). At present the majority of research on engineered nanomaterials 
has focused on those which are anticipated to be produced in commercial quantities in 
the near future such as carbon nanotubes. The toxicity and biocompatibility of these 
materials (Fiorito et al 2006; Smart et al 2006) and the relevance to occupational health 
(Donaldson et al 2006; Lam et al 2006) have been reviewed elsewhere.
Carbon nanotubes (CNT) are one of the most studied nanomaterials because 
of their novel physicochemical properties which include high surface area, high International Journal of Nanomedicine 2008:3(3) 374
Journeay et al
mechanical strength yet ultra-light weight, rich electronic 
properties and chemical and thermal stability (Ajayan 1999). 
Two common types of CNT are the single-walled carbon 
nanotubes (SWNT) that are formed by a cylindrical sheet of 
graphite with a diameter of 0.4–2 nm, and the multi-walled 
carbon nanotubes (MWNT) that have multiple concentric 
graphite cylinders with increasing diameter ranging from 
2–200 nm (Dresselhaus et al 1996). SWNT have received 
attention primarily as a possible inhalation toxicant in their 
raw form (Lam et al 2004; Warheit et al 2004; Shvedova 
et al 2005), but carbon nanotubes also have potential for 
biomedical applications (Bianco and Prato 2003; Martin 
and Kohli 2003; Bianco 2004; Lin et al 2004). In order for 
CNT to be used for biomedical purposes they typically need 
to become soluble with the addition of surface molecules 
(Georgakilas et al 2002; Pantarotto et al 2003; Hudson et al 
2004; Lin et al 2004). Indeed, the in vitro toxicity of carbon 
nanomaterials, such as fullerenes and SWNT, has been shown 
to be dependent upon the degree of surface functionalization 
(Sayes et al 2004, 2005).
Self-assembled rosette nanotubes (RNT) are a novel class 
of biologically inspired nanotubes that are naturally water-
soluble upon synthesis (Fenniri et al 2001, 2002a, 2002b). 
The RNT are obtained through the self–assembly of the G∧C 
motif, a self–complementary DNA base analogue featuring 
the complementary hydrogen bonding arrays of both gua-
nine and cytosine (Figure 1). The ﬁ  rst step of this process is 
the formation of a 6-membered supermacrocycle (rosette) 
maintained by 18 hydrogen bonds, which then self–organizes 
into a tubular stack deﬁ  ning an open central channel 1.1 nm 
across and several micrometers long (Figure 1) (Fenniri et al 
2001, 2002a, 2002b; Raez et al 2004; Moralez et al 2005; 
Johnson et al 2007). Upon self-assembly, in principle any 
functional group covalently attached to the G∧C motif could 
be expressed on the surface of the nanotubes, thereby offer-
ing versatility in functionalization of the RNT for speciﬁ  c 
medical or biological applications. Moreover, the RNT are 
void of any metals, which confers potential advantage to 
their biocompatibility given reports on the role of metals in 
particle-induced oxidative stress (Ghio et al 1999; Donaldson 
et al 2006). Several hydrophilic RNT have been reported, 
displaying chiroptical (Fenniri et al 2002a; Johnson et al 
2007) and hierarchical (Moralez et al 2005) tunability, high 
thermal stability (Fenniri et al 2002b; Moralez et al 2005) 
and entropically-driven self-assembly behavior (Fenniri et al 
2002b) in polar solvents.
Compound 1-G0 (Figure 1) was previously shown to 
undergo self-assembly into RNT by NMR spectroscopy, cir-
cular dichroism (CD) spectroscopy, variable temperature UV-
vis melting studies, dynamic light scattering (DLS), tapping 
mode atomic force microscopy (TM-AFM), and transmission 
electron microscopy (TEM). In agreement with the calculated 
average diameter of 3.8 nm, TEM images of RNT(1) featured 
a diameter of 4.0 ± 0.3 nm (Moralez et al 2005).
Compound 1-G0 was designed relative to other compounds 
(Moralez et al 2005) so that upon self-assembly (a) the 
functional group density and net charge are reduced by a 
factor of two (b) the thermal stability of the corresponding 
RNT is enhanced as a result of preorganization, increased 
amphiphilic character, and greater number of H-bonds per 
module (12 instead of 6), (c) the corresponding twin rosettes 
are preorganized and maintained by 36 H-bonds instead of 
18, and (d) the resulting RNT(1)-G0 is sterically less con-
gested and experiences reduced electrostatic repulsion on 
its surface. These design criteria made RNT(1)-G0 far more 
robust relative to its single base congeners (Moralez et al 
2005), even in boiling water.
To date, RNT have only been investigated for application 
to biomaterial interfaces in the ﬁ  eld of orthopedics and 
speciﬁ  cally as a way to promote osteoblast adhesion in vitro 
(Chun et al 2004, 2005). No data exist on the in vivo responses 
to exposure of these speciﬁ  c nanotubes and furthermore there 
are no studies on the responses to functionalized nanotubes 
in the lungs. We have chosen to evaluate the pulmonary 
responses because of the variety of potential applications 
of RNT including drug delivery (Hung  2006) and the 
Twin Rosette RNT (1)
Figure 1 Rosette nanotubes (G0) assembled from compound 1 and corresponding 
transmission electron micrographs. Scale bars in nm.International Journal of Nanomedicine 2008:3(3) 375
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relative paucity of toxicity information on functionalized 
self-assembling nanostructures. Furthermore inﬂ  ammatory 
physiology in the lung is well characterized, and is therefore 
a good model organ for studying the possible immunologic 
responses to RNT.
Materials and methods
Animals
All animal protocols in this study were approved by the 
University of Saskatchewan Committee on Animal Care 
Assurance, and each experimental procedure was conducted 
according to the Canadian Council on Animal Care Guidelines. 
A total of forty-two 6–8-weeks-old, speciﬁ  c pathogen-free, male 
C57BL/6 mice were procured from the animals resource unit at 
the University of Saskatchewan, Canada (n = 6 per group). The 
mice weighed 25–30 g. The animals were acclimatized for a 
period of 1 week in the animal care unit prior to experimenta-
tion, and were randomly assigned to treatment groups.
RNT(1)-G0 preparation
and characterization
The nanotubes were formed by mixing 1 mg of compound 
1(G0) in 1ml of nanopure, sterile water and heating at 90 °C 
for ∼30 min. The self-assembly process is quantitative, thus 
1mg of compound 1 yields 1 mg of RNT(1)-G0. Based on scan-
ning and transmission electron microscopy, the length of the 
nanotubes is polydisperse. But the synthetic protocol employed 
here yields tubes that are several microns long. Without a heat-
ing protocol they range from 50–200 nm in length. Regardless of 
the length, RNT(1)’s outer diameter is ∼4 nm. Their calculated 
surface area is ∼104 m2/g. The aggregation state of RNT(1)-G0 
is pH-dependent: as the protonation state of the lysine changes, 
the nanotubes aggregate in a parallel fashion (Moralez et al 
2005). At low pH they are well dispersed however their status 
upon being introduced to the lung environment is unknown.
Experimental overview
Mice were studied at different doses of RNT(1)-G0 at two 
time points. The ﬁ  rst experiment was conducted by treating 
C57/BL mice with RNT(1)-G0 intratracheally (5, 25, 50 μg 
in 50 μl of nanopure water/mouse). Two control groups 
included mice treated with 50 μl of nanopure water, or 50 μg 
of lysine in 50 μl of nanopure water. The lysine group was 
used as control for the lysine component of the nanotube 
surface. These mice were euthanized at 24 h. In a second 
group of mice, we examined the effect of 5 and 50 μg doses 
at 7 days post instillation. This experiment was selected based 
on our 24 h time point results. We wished to test if a 5 μg 
dose triggered an inﬂ  ammatory response by 7d and whether 
the inﬂ  ammatory response measured in our 50 μg group 
resolved by 7d. Thus an intermediate dose of 25 μg was not 
studied at the 7d time-point. Doses were chosen based on the 
range used by other studies investigating SWNT pulmonary 
toxicity (Shvedova et al 2005).
We evaluated the extent of the inﬂ  ammatory response 
by examining the bronchoalveolar lavage (BAL) total 
and differential cell counts as well as the peripheral blood 
total leukocyte count (TLC). Changes in lung permeability 
were assessed using BAL ﬂ  uid protein as a marker. The 
chemokine macrophage inﬂ  ammatory protein-2 (MIP-2) and 
the cytokines interleukin-1Beta (IL-1β) and tumor necrosis 
factor-alpha (TNF-α) were measured in the BAL ﬂ  uid and 
lung homogenate. Changes to the mRNA levels of MIP-2, 
IL-1β, and TNF-α were also assessed using quantitative real 
time RT-PCR (qRTPCR). Histological evaluation of the 
lavaged lung tissue was performed using the hemotoxylin 
and eosin (H&E)-staining technique.
Lung collection and processing, and cell 
counts
Mice were euthanized (1 mg xylazine and 10 mg 
ketamine/100 g) and blood, BAL ﬂ  uid, and lung samples were 
collected. Blood was collected by cardiac puncture for total 
leukocyte counts. BAL was performed by washing the whole 
lung with 3 ml (1 ml × 3 washes) of ice-cold Hanks Balanced 
Salt Solution (Sigma Chemicals Co., St. Louis, MO). Total 
cell count was performed using a standard hemocytomter. 60 
μl of BAL ﬂ  uid was used for a cytospin preparation on which 
the polymorphonuclear and monocyte differential counts were 
performed. Blood was collected by cardiac exsanguination 
and processed for evaluation on total leuckocyte count on the 
hemocytometer. One lung was ﬁ  xed in 4% paraformaldehyde 
for 16 hours. Lungs used for quantiﬁ  cation of cells were ﬁ  lled 
with 4% paraformaldehyde at 23 cm H2O pressure. We col-
lected pieces from the same lobes of lungs from all the mice 
and were later processed through ascending grades of alcohol 
and then embedded in parafﬁ  n. Tissue blocks were then cut 
into 5 μm sections for light microscopy. H&E-stained sections 
were used for histopathological evaluation.
Histopathology
The H&E-stained lung sections were evaluated by two 
independent observers. One of the observers was blinded 
to the identity of treatment groups. The tissue changes were 
subjectively graded for no inﬂ  ammation, mild inﬂ  ammation, 
and high inﬂ  ammation.International Journal of Nanomedicine 2008:3(3) 376
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Enzyme-linked immunosorbent assay 
for MIP-2, IL-1β, and TNF-α
Enzyme-linked immunosorbent assay (ELISA) was con-
ducted on both the BAL ﬂ  uid and the lung tissue. For lung 
tissue analysis, frozen lung samples were homogenized in 
lysis buffer (150 mM sodium chloride, 1% NP-40, 0.5% 
sodium deoxycholate, 0.1% SDS, 50 mM TRIS [pH 8.0], 
5 mM EDTA, and protease inhibitor cocktail [100 μl/10 ml]). 
Homogenates were collected after centrifuging the samples 
at 25,000 g for 20 minutes. For quantiﬁ  cation, samples in 
duplicates, from 3 mice for each treatment were used. IL-1β, 
TNF-α, and MIP-2 were quantiﬁ  ed by sandwich ELISA 
using antibody pairs and recombinant standards purchased 
from R&D Systems (Minneapolis, MN, USA). For the lung 
homogenate analysis each well was loaded with 20 μg of 
protein.
BAL ﬂ  uid total protein assay
Total protein in the BAL ﬂ  uid supernatant was quantiﬁ  ed 
using an assay kit from Bio-Rad Laboratories (Hercules, CA, 
USA) as per the manufacturer’s protocol. The protein assay 
is based on the Bradford method of protein quantiﬁ  cation. 
Protein concentration values were calculated from a standard 
curve using bovine serum albumin (BSA) concentrations 
ranging from 0 to 1.0 mg/ml.
RNA isolation and real time 
reverse-transcriptase polymerase 
chain reaction (qRTPCR)
Total RNA was extracted from the lungs of mice by using 
TRIzol reagent (Invitrogen, Ontario, Canada) followed 
by treatment with RNase-free DNase (Qiagen, Ontario, 
Canada) and puriﬁ  cation on RNeasy mini columns (Qiagen) 
according to the manufacturer’s instructions. Integrity of 
RNA was conﬁ  rmed by agarose gel electrophoresis and RNA 
was quantiﬁ  ed by spectrophotometric analysis. The mRNA 
was reverse transcribed at 42 °C for 40 min by using Stra-
taScript QPCR cDNA synthesis kit (Stratagene, USA) and 
universal oligo dT primer as per manfacturer’s instructions. 
This cDNA was used for QRtPCR analysis for the expres-
sion of TNF-α; (GenBank Accession No. NP_038721), 
MIP-2; (GenBank Accession No. X53798), and IL-1β; 
(GenBank Accession No. NP_032387) genes using Brilliant 
SYBR Green QPCR kit (Stratagene). The glyceraldehyde-
3-phosphate dehydrogenase gene (GAPDH; GenBank 
Accession No. XR004536) was used as the reference 
housekeeping gene. The reactions were performed using 
the primer pairs; 5′-ATGAGCACAGAAAGCATG-3′ 
and 5′-GGGAACTTCTACTCCCTT-3′ for TNF-α, 
5′-ATGGCCCCTCCCACCTGC-3′ and 5′-ACTTCTGTCT-
GGGCGCAG-3′ for MIP-2, 5′-ATGGCAACTGTTCCT-
GAA-3′ and 5′-GCCACAGCTTCTCCACAG-3′ for IL-1β 
and 5′-TGCATCCTGCACCACCAACTG-3′ and 5′-GGGC-
CATCCACAGTCTTCTGG-3′ for GAPDH. A negative 
control reaction consisted of all the components of the 
reaction mixture except RNA. Real-time PCR analysis was 
performed using the MX3005PLightCycler (Stratagene). 
The cDNA was denatured at 95 °C for 5 minutes. This 
was followed by ampliﬁ  cation of the target DNA through 
45 cycles of denaturation at 95 °C for 1 min, annealing at 
55 °C for 30 seconds and elongation at 72 °C for 30 seconds. 
Relative expression levels were calculated after correction for 
expression of GAPDH using MxPro software (Stratagene).
Data analysis
Statistical analysis was carried out with SigmaStat statistical 
software (Systat Inc., Chicago, IL, USA). Values represent the 
means ± SD. Comparisons between 24 h treatment groups were 
performed using a one-way ANOVA. When signiﬁ  cant main 
effects were observed, a Tukey’s post hoc test was performed. 
Differences were considered signiﬁ  cant when P   0.05. An 
unpaired Student’s t-test was used to examine differences 
between 24 h and 7d for the doses of 5 μg and 50 μg.
Results
BAL ﬂ  uid and blood cell counts
The total number of cells observed in the BAL ﬂ  uid showed 
a dose dependent effect in the 24 h treatment groups. Only 
25 μg and 50 μg groups differed from each other and showed 
increased total cell counts (Figure 2A), polymorphonuclear 
cells (PMN) (Figure 2B) and monocyte counts (Figure 2C) 
compared to the control, lysine, and 5 μg treatment groups 
(P   0.001). There were no differences in total cells 
(Figure 2A), PMN (Figure 2B; P = 0.103) and monocytes 
(Figure 2C; P = 0.901) in the 5 μg group between 24 h and 
7d treatments but 50 μg group showed a reduction in all cell 
types at 7d compared to 24 h (Figure 2A; P = 0.001).
Total leukocyte counts in the blood did not differ between 
any groups at 24 h. The 5 μg and 50 μg dose groups did not 
differ between the 24 h and 7d time-points (Figure 3).
Bronchoalveolar lavage ﬂ  uid total 
protein assay
There were no differences in BAL ﬂ  uid protein concentrations 
among any of the groups (Figure 4). We however would like to International Journal of Nanomedicine 2008:3(3) 377
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note that the 50 μg treatment group approached signiﬁ  cance when 
compared with all the other groups at 24 h (Figure 4; P = 0.07).
ELISA for TNF-α, IL-1β, and MIP-2
Lavage ﬂ  uid analysis
ELISA was performed on both the lavage ﬂ  uid and on tissue 
homogenate. The cytokines IL-1β and TNF-α were found 
to be below detectable levels in the lavage ﬂ  uid (data not 
shown) and there were no differences in MIP-2 concentra-
tions between any of the groups (Figure 5).
Tissue homogenate analysis
At 24 h, levels of TNF-α in the lung tissue of mice treated with 
5 μg and 25 μg were greater than both the control- (P = 0.004 
and P = 0.04) and lysine-treated (P   0.001 and P = 0.003) 
groups (Figure 6A). The 50 μg did not differ from control but 
did differ from the lysine-treated group (P = 0.005). No differ-
ences were detected between nanotube treatment groups at 24 h 
(Figure 6A). The amount of TNF-α approached a statistically 
signiﬁ  cant decrease between 24 h and 7d in the 5 μg groups 
(P = 0.056), and did not differ in the 50 μg group (P = 0.231).
IL-1β levels (Figure 6B) did not differ between the 
control- and lysine-treated groups. While the 5 μg group 
showed a greater amount of IL-1β than both the control 
and lysine groups, the 25 μg and 50 μg levels were only 
greater than the lysine group. Levels did not differ between 
the nanotubes groups at 24 h. At 7d, IL-1β concentration in 
the tissue was 0.029). In the 50 μg treatment, levels did not 
differ between 24 h and 7d (P = 0.260).
MIP-2 levels did not differ between all treatment groups 
at 24 h (Figure 6C). When comparing MIP-2 levels in the 5 μg 
groups at 24 h and 7d no difference was detected, however 
in the 50 μg group levels of MIP-2 were higher at 24 h than 
at 7d (P < 0.001).
Quantitative real time RT-PCR TNF-α, IL-
1β, and MIP-2
When compared to control lungs, the lysine and 5 μg groups 
showed a ∼3-fold reduction in TNF-α mRNA (Figure 7A; 
P < 0.001), while the 25 μg group was the same as control and 
the 50 μg had a ∼2 fold increase in TNF-α mRNA at 24 h. In 
the 5 μg group the level of TNF-α mRNA at 7d did not differ 
from control lungs (P = 0.378), while the 50 μg treatment group 
had a ∼2-fold lower level of mRNA than control (P = 0.02). 
IL-1β transcription was increased relative to control lungs in 
all nanotube-treated groups at 24 h, however the lysine-treated 
group did not differ from control (Figure 7B; P   0.001). At 7d, 
mRNA remained elevated above control in the 5 μg (P = 0.004) 
and 50 μg (P = 0.025) treatment groups. MIP-2 mRNA was 
reduced at 24h relative to control in the lysine-, 5 μg- and 
25 μg-treated lungs (Figure 7C; P   0.001) and approached 
statistical signiﬁ  cance in the 50 μg treatment group at 24h 
(P = 0.058). At 7d, the 5 μg-treated lungs did not differ from 
control (P = 0.528) however the 50 μg treatment group showed 
a signiﬁ  cant reduction in mRNA levels at 7d (P   0.001).
Histology
When compared to control- (Figure 8A), 5 μg- (Figure 8B) 
and lysine-treated (not shown) lungs, the 25 μg- (not shown) 
and 50 μg-treated (Figure 8C) lungs showed septal thicken-
ing, edema, and inﬂ  ux of cells at 24 h. When examined at 
7d post-instillation (Figure 8D), the 50 μg-treated lungs 
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lavage ﬂ  uid from mice at 24 h and 7d.
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lysine and 5 μg groups at 24 h (P   0.05). **denotes signiﬁ  cant difference from all other 
groups at 24 h. †denoted different from same treatment dose at 24 h (P   0.05).International Journal of Nanomedicine 2008:3(3) 378
Journeay et al
showed less septal congestion and inﬂ  ux of cells relative to 
the 24 h lungs (Figure 8C). There was perivascular dilatation 
at 24 h in lungs exposed to 25 and 50 μg doses but not in the 
other treatment groups or time points (data not shown). No 
evidence of granuloma formation was apparent.
Discussion
We present the ﬁ  rst in vivo data on the acute inﬂ  ammatory 
potential of self-assembled rosette nanotubes in the lungs of 
C57/BL mice. Moreover, these are the ﬁ  rst toxicity screening 
data on a synthetic organic nanomaterial and add to the literature 
on the interaction of functionalized nanotubes with biologi-
cal systems in vitro (Pantarotto et al 2003; Sayes et al 2005; 
Dumortier et al 2006; ). The key ﬁ  ndings from this study are that 
C57/BL mice do not show signs of lung inﬂ  ammation at the dose 
of 5 μg at 24 h and no response is triggered by 7d. Additionally, 
while a dose of 50 μg triggered signiﬁ  cant lung inﬂ  ammatory 
responses at 24 h, the effects are resolving by 7d.
The intratracheal instillation technique was chosen as an 
exposure method in this screening study of RNT. While there 
are advantages and disadvantages of this technique (Driscoll 
et al 2000; Oberdörster et al 2005a), instillation studies are 
qualitatively a positive predictor of particle-induced pathology. 
Moreover, within the ﬁ  eld of inhalation toxicology, a reliable 
method of delivering nanotubes via aerosol or inhalation cham-
ber is still being devised and pulmonary deposition patterns of 
nanotubes upon inhalation remain unresolved. It should also 
be noted that the dose range used here is similar to previous 
work in SWNT where oropharyngeal aspiration was used to 
deliver the material to the lungs (Shvedova et al 2005).
Our initial examination of the pulmonary response to instil-
lation of the nanotubes included the evaluation of inﬂ  ammatory 
cells in the bronchoalveolar lavage ﬂ  uid (Henderson 2005). 
A signiﬁ  cant inﬂ  ux of total cells was observed in our 25 μg 
and 50 μg dose treatment groups at 24 h compared with our 
control and lysine groups. The compound in this study is 
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a lysine based rosette nanotube (Figure 1), and thus in an 
attempt to delineate the possible role of lysine versus the 
nanotube structure, lysine was used as an additional control. 
As lysine did not trigger an inﬂ  ux of inﬂ  ammatory cells, we 
attribute the observed inﬂ  ammation at 24 h to an effect of the 
nanotube structure per se and not the lysine component.
While acute inﬂ  ammatory responses are important in the 
study of particle toxicology, the resolution of such responses 
is crucial to understanding the longer-term effects. We tested 
whether the 5 μg dose triggered inﬂ  ammation by 7d post treat-
ment and additionally whether the inﬂ  ammation observed at 
24 h in the 50 μg dose resolved. Of note, the 5 μg dose did not 
induce an inﬂ  ux of cells at 7d and the 50 μg treatment showed 
signiﬁ  cant reduction in cell total number compared with 24 
h. The absolute PMN and monocyte count also paralleled 
the responses of the total cell count. It should be emphasized 
that while instillation of particles into the lungs may cause 
an acute inﬂ  ammatory response due to the bolus nature of 
the exposure, the lung is a resilient organ that can resolve the 
effects of modest acute insults after exposure to such toxi-
cants as particulate matter. Thus, particulate nanomedicine 
delivery systems such as functionalised nanotubes (Moghimi 
and Kissel 2006) may be useful for nonchronic delivery of 
therapies to the lung (Hung 2006; Pison et al 2006), provided 
no persistent pathology is caused. In addition to the lung 
response, we also determined whether nanotube instillation 
caused a peripheral immune response, as determined by blood 
total leukocyte count. Contrary to what is observed upon expo-
sure to particulate matter where monocytes may be released 
from bone marrow (Goto et al 2004), we did not observe any 
differences in total leukocyte count in the blood between any 
treatment groups, and conclude that a peripheral response was 
not evoked by pulmonary exposure to the nanotubes. The BAL 
ﬂ  uid cell counts were also supported through histological 
evidence of congestion, accumulation of inﬂ  ammatory cells 
in alveolar septa, and dilatation of perivascular spaces in 
lungs of mice treated with 25 and 50 μg of nanotubes at 24 h 
but not at 7d (a 25 μg group was not observed at 7 d). Lung 
sections from 5 μg group did not show signs of inﬂ  ammation 
at both 24 h and 7d of treatment. In toto, these data support 
induction of lung inﬂ  ammation by 24 h at the higher doses of 
RNT used in this study, which is resolving by 7d.
As a marker of lung permeability changes we measured 
total protein in the lavage ﬂ  uid. Of note, while a signiﬁ  cant 
increase in BAL ﬂ  uid total cell number was observed in 
both the 25 μg and 50 μg groups, neither group showed a 
signiﬁ  cant change in lung permeability. When measured at 
7d post-treatment total protein in the lavage ﬂ  uid had not 
changed from 24 h in the 5 or 50 μg groups. The protein data 
are in contrast to evidence of edema in hematoxylin-eosin 
stained subjectively assessed lung sections collected at 24 h 
from the high dose groups. The signs of edema, however, 
were resolving by 7d. Dailey and colleagues (2006) observed 
a reduced level of BAL protein at 14d relative to 24 h when 
they compared BAL protein levels at 24 h and 14d after 
instillation of ﬁ  ne (220 nm) polystyrene nanoparticles. They 
did observe however that treatment with ultraﬁ  ne (75 nm) 
polystyrene particles resulted in a persistent elevation in 
BAL protein levels at 14d when compared with 24 h. Taken 
together with the reduction in total cell count in the present 
study, these responses are suggestive of resolution of inﬂ  am-
mation occurring between 24 h and 7d.
In order to assess the possible molecular contributors to 
the acute inﬂ  ux of cells we examined the expression of the 
cytokines TNF-α and IL-1β and the chemokine MIP-2 in both 
the lavage ﬂ  uid and the lung tissues. We also studied mRNA 
expression of these inﬂ  ammatory mediators in lung tissues with 
qRT-PCR. While TNF-α and IL-1β are central players in acute 
lung inﬂ  ammation (Goodman et al 2003), MIP-2 promotes 
migration of inﬂ  ammatory cells (Kobayashi 2006).
Mouse lungs treated with 5 μg of nanotubes showed 
higher TNF-α and IL-1β protein concentrations compared 
to control- and lysine-treated tissues at 24h while the 50 μg 
group differed from lysine but not the control group. Lung tis-
sues from mice treated with 25 μg showed higher concentra-
tion of TNF-α compared to both lysine and control but IL-1β 
levels were more than the lysine group only. While IL-1β 
mRNA was increased in all the nanotube-treated groups 
compared to the control, TNF-α mRNA was elevated in the 
50 μg group only. TNF-α mRNA levels were reduced in the 
5 μg group compared to the control. Although there is a 
discrepancy in the expression of IL-1β protein and mRNA 
in the 5 μg group, we judge the protein data to be of more 
importance because protein is the functional product of gene 
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transcription. Furthermore, it is well known that all of the 
mRNA may not be translated into a mature protein. TNF-α 
and IL-1β are released by lung macrophages, epithelium, and 
endothelium in response to a variety of stimuli such as endo-
toxin and bacteria (Goodman et al 2003). These cytokines 
induce expression of adhesion molecules such as selectins 
and integrins to facilitate migration of inﬂ  ammatory cells 
such as neutrophils and monocytes (Goodman et al 2003). 
Even though expression of the chemokine MIP-2 remained 
unaltered at 24 h post-treatment, there was an increase in 
monocytes in BAL ﬂ  uid. It is well known that monocyte and 
neutrophil migration is promoted though a complex interplay 
of many chemokines and adhesion molecules such as MCP-1, 
IL-8 and integrin αvβ3 (Janardhan et al 2006; Kobayashi 
2006). The increased expression of cytokines in the 5 μg 
group did not result in higher migration of inﬂ  ammatory 
cells into lungs. Nevertheless, increased numbers of cells in 
the lungs of mice treated with 25 and 50 μg of nanotubes 
could be a functional outcome of increased expression of 
TNF-α and IL-1β.
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Acute lung inﬂ  ammation induced by a single application 
of a stimulus normally resolves through migration of 
inﬂ  ammatory cells out of the lung. Therefore, we examined 
lung tissues at 7d post-treatment. Histological examina-
tion showed some resolution of inﬂ  ammation in the 50 μg 
group along with a decrease in MIP-2 protein levels despite 
unaltered protein expression of TNF-α and IL-1β. MIP-2 is 
a central chemokine in bacterial sepsis and oxidant-induced 
lung injury (Dailey et al 2006) and promotes recruitment of 
neutrophils and monocytes (Goodman et al 2003). Previous 
work on other classes of nanotubes has clearly indicated the 
role of metals used in the synthetic process and the associated 
oxidative stress response (Donaldson et al 2006). A critical 
aspect of the RNT studied here is the absence of metals in 
the synthetic process of the compound. Thus, the measure-
ment of MIP-2 was considered an important end-point. 
MIP-2 was detected in both the lavage ﬂ  uid and the tissue 
homogenate, but no differences in MIP-2 were detected 
between treatment groups in the lavage ﬂ  uid at 24 h or 7d. 
Furthermore, while no changes were detected in the tissue 
at 24 h, a statistically signiﬁ  cant decrease in MIP-2 was 
detected at 7d compared to 24 h in the 50 μg group. Despite 
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few changes in MIP-2 protein among treatments, all groups 
showed a decrease in MIP-2 mRNA relative to control. This 
is in contrast to previous data (Dailey et al 2006) showing an 
increase in MIP-2 mRNA expression after treatment with bio-
degradable polymeric nanoparticles and nonbiodegradable 
polystyrene nanoparticles. A reduction in MIP-2 expression 
may be responsible for reduced numbers of inﬂ  ammatory 
cells and suggest resolution of inﬂ  ammation in RNT-treated 
animals. Taken together, these data show that 5 μg and 50 μg 
may represent noninﬂ  ammatory and inﬂ  ammatory doses, 
respectively, of this nanotube and provide a framework for 
their further toxicity characterization.
The RNT are by design water-soluble and metal free. 
Thus their rapid synthesis and subsequent administration 
in water does not allow for easy visualization in vivo upon 
histological examination. However, the observed differ-
ence in responses between doses shows that our instillation 
method was successful in exposing the lung to this organic 
nanomaterial. A labeled version of the RNT is currently being 
developed for in vitro and in vivo uptake and distribution 
studies. Due to the fact that we could not visualize the tubes in 
vivo, the aggregation state in the lung could not be ascertained. 
While the aggregation state of this RNT is pH-dependent 
when studied under laboratory conditions, it is not known 
whether these observations can be extended to behaviour in 
physiological ﬂ  uids such as lung surfactant. Indeed, a paucity 
of information exists on the interaction of nanomaterials with 
components of the physiological environment.
Summary
Here we presented the ﬁ  rst in vivo study on rosette nanotubes 
which is also the ﬁ  rst of its kind for an organic nanomate-
rial obtained through self-assembly. Moreover, the biologi-
cally inspired design of the rosette nanotubes may confer 
toxicological advantages over other nanotube compounds 
for biomedical application. This requires further study as the 
present experiments did not establish the relative toxicity of 
the rosette nanotubes to other nanostructures or traditional 
particulate toxicants such as silica. The data demonstrated 
that a 5-μg dose of RNT(1) is well tolerated in murine lungs 
up to 7d post-instillation, and that even with a 50 μg dose, 
inﬂ  ammation is resolving by 7d. Future studies should 
examine the uptake and distribution kinetics of the RNT in 
vitro and in vivo. In light of many reports of nanomaterial-
induced toxicity, our study presents an example of how 
a biologically inspired synthetic nanomaterial created on 
Figure 8 Hematoxylin and eosin-stained lung sections. Lung sections from mice Control (A) and 5 μg treated mice (B) show normal alveolar septa (arrows) while those 
from 50 μg at 24 h (C) show septal congestion (inset), septal thickening and edema (arrows). Section of a lung collected 7d post-instillation of 50 μg of RNT (D) shows nearly 
normal alveolar septa (arrows) and some congestion (arrows). Original magniﬁ  cation: X40.International Journal of Nanomedicine 2008:3(3) 383
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the principle of self-assembly can be introduced into the 
mammalian system without the development of serious 
adverse pulmonary effects. Moreover, our data may provide 
a framework to encourage future novel nanomaterials that are 
toxicologically favorable due to their biologically inspired 
and self-assembling architectures.
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